Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study

INTRODUCTION: Severe asthma is associated with airway inflammation and airway obstruction. In the phase 3 NAVIGATOR study, tezepelumab treatment significantly improved pre-bronchodilator forced expiratory volume in 1 s (FEV(1)) compared with placebo in patients with severe, uncontrolled asthma. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Menzies-Gow, Andrew, Ambrose, Christopher S., Colice, Gene, Hunter, Gillian, Cook, Bill, Molfino, Nestor A., Llanos, Jean-Pierre, Israel, Elliot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567907/
https://www.ncbi.nlm.nih.gov/pubmed/37723356
http://dx.doi.org/10.1007/s12325-023-02659-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567907/
https://www.ncbi.nlm.nih.gov/pubmed/37723356
http://dx.doi.org/10.1007/s12325-023-02659-y

Ejemplares similares